⌕
iShares Biotechnology ETF · IBB · Nasdaq
A sector position · not Tenet-scored
Compare
$207.98−2.13%At close
$207.98−4.52 (−2.13%)
At close: Nov 16, 2026, 4:00 PM ET· Nasdaq · USD

IBB Holdings

IBB holds 243 positions as of Nov 12, 2026; the largest are GILD at 8.9%, AMGN at 8.3% and VRTX at 7.7%.

Sources Fund holdings disclosures Fund disclosuresHoldings as of How we compute thisNot investment advice
Positions
243
as of Nov 12, 2026
Largest holding
GILD 8.9%
One position carries outsized weight. Check it fits your view.
Top-10 share
51.3%
Concentrated — its ten largest names are ~51% of the fund.

Weights exclude the cash/collateral sleeve (0.1%).

Largest 100 of 243

#TickerCompanyWeightCumulative · to 94.7%
1GILDGILEAD SCIENCES8.9%
8.9%
2AMGNAMGEN INC8.3%
17.2%
3VRTXVERTEX PHARMACEUTICALS7.7%
24.9%
4REGNREGENERON PHARMACEUTICALS6.4%
31.3%
5MRNAMODERNA6.2%
37.5%
6ARGXARGENX SE ADR3.7%
41.1%
7NTRANATERA2.9%
44.0%
8BIIBBIOGEN2.5%
46.5%
9ONCBEONE MEDICINES AG2.4%
48.9%
10RVMDREVOLUTION MEDICINES2.4%
51.3%
11ILMNILLUMINA INC2.2%
53.5%
12GMABGENMAB SPONSORED ADR2.0%
55.5%
13INSMINSMED1.8%
57.2%
14UTHRUNITED THERAPEUTICS1.7%
58.9%
15INCYINCYTE CORP1.7%
60.6%
16ROIVROIVANT SCIENCES LTD1.5%
62.0%
17ALNYALNYLAM PHARMACEUTICALS1.4%
63.5%
18NBIXNEUROCRINE BIOSCIENCES1.2%
64.7%
19EXELEXELIXIS INC1.1%
65.8%
20CRLCHARLES RIVER LABORATORIES INTERNA1.1%
66.9%
21ASNDASCENDIS PHARMA1.1%
68.0%
22MEDPMEDPACE HOLDINGS1.0%
69.0%
23BBIOBRIDGEBIO PHARMA0.9%
70.0%
24HALOHALOZYME THERAPEUTICS0.8%
70.7%
25TECHBIO TECHNE0.8%
71.5%
26BMRNBIOMARIN PHARMACEUTICAL0.8%
72.3%
27RGENREPLIGEN0.7%
73.0%
28KYMRKYMERA THERAPEUTICS0.7%
73.6%
29PCVXVAXCYTE0.7%
74.3%
30MDGLMADRIGAL PHARMACEUTICALS0.6%
74.9%
31PRAXPRAXIS PRECISION MEDICINES0.6%
75.5%
32TEMTEMPUS AI CLASS A0.6%
76.1%
33SYRESPYRE THERAPEUTICS INC0.6%
76.7%
34BNTXBIONTECH SE ADR0.6%
77.3%
35PTGXPROTAGONIST THERAPEUTICS0.6%
77.8%
36KRYSKRYSTAL BIOTECH0.5%
78.4%
37TWSTTWIST BIOSCIENCE0.5%
78.9%
38CYTKCYTOKINETICS0.5%
79.4%
39ALKSALKERMES0.5%
80.0%
40RYTMRHYTHM PHARMACEUTICALS0.5%
80.5%
41TXG10X GENOMICS CLASS A0.5%
80.9%
42BRKRBRUKER0.5%
81.4%
43ABVXABIVAX AMERICAN DEPOSITARY SHARES0.5%
81.9%
44AXSMAXSOME THERAPEUTICS0.4%
82.3%
45ARWRARROWHEAD PHARMACEUTICALS0.4%
82.8%
46KODKODIAK SCIENCES0.4%
83.2%
47ORKAORUKA THERAPEUTICS0.4%
83.6%
48GRALGRAIL INC0.4%
84.0%
49PTCTPTC THERAPEUTICS0.3%
84.3%
50MIRMMIRUM PHARMACEUTICALS0.3%
84.7%
51TVTXTRAVERE THERAPEUTICS0.3%
85.0%
52ADPTADAPTIVE BIOTECHNOLOGIES0.3%
85.3%
53SRRKSCHOLAR ROCK HOLDING0.3%
85.6%
54IONSIONIS PHARMACEUTICALS0.3%
85.9%
55COGTCOGENT BIOSCIENCES0.3%
86.2%
56DFTXDEFINIUM THERAPEUTICS INC0.3%
86.5%
57CGONCG ONCOLOGY0.3%
86.8%
58ERASERASCA0.3%
87.1%
59CRSPCRISPR THERAPEUTICS AG0.3%
87.4%
60EWTXEDGEWISE THERAPEUTICS0.3%
87.6%
61XENEXENON PHARMACEUTICALS0.3%
87.9%
62CDNACAREDX0.3%
88.2%
63TNGXTANGO THERAPEUTICS0.2%
88.4%
64TARSTARSUS PHARMACEUTICALS0.2%
88.6%
65AMLXAMYLYX PHARMACEUTICALS0.2%
88.9%
66RLAYRELAY THERAPEUTICS0.2%
89.1%
67LEGNLEGEND BIOTECH ADR REP0.2%
89.3%
68IOVAIOVANCE BIOTHERAPEUTICS INC0.2%
89.5%
69IMVTIMMUNOVANT0.2%
89.7%
70ACADACADIA PHARMACEUTICALS0.2%
90.0%
71CAICARIS LIFE SCIENCES0.2%
90.2%
72ARQTARCUTIS BIOTHERAPEUTICS0.2%
90.4%
73ELVNENLIVEN THERAPEUTICS0.2%
90.6%
74VCELVERICEL0.2%
90.8%
75IDYAIDEAYA BIOSCIENCES0.2%
91.0%
76ABCLABCELLERA BIOLOGICS0.2%
91.2%
77DNLIDENALI THERAPEUTICS0.2%
91.4%
78ADMAADMA BIOLOGICS0.2%
91.6%
79XNCRXENCOR0.2%
91.8%
80DYNDYNE THERAPEUTICS0.2%
92.0%
81IBRXIMMUNITYBIO0.2%
92.1%
82SMMTSUMMIT THERAPEUTICS0.2%
92.3%
83ZLABZAI LABORATORY ADR REPRESENTING LT0.2%
92.5%
84IRONDISC MEDICINE0.2%
92.6%
85BEAMBEAM THERAPEUTICS0.2%
92.8%
86GRFSGRIFOLS ADR REPRESENTING ONE NON-V0.1%
92.9%
87ZYMEZYMEWORKS0.1%
93.1%
88VCYTVERACYTE0.1%
93.2%
89BHVNBIOHAVEN0.1%
93.3%
90RXRXRECURSION PHARMACEUTICALS CLASS A0.1%
93.5%
91FTREFORTREA HOLDINGS INC0.1%
93.6%
92AGIOAGIOS PHARMACEUTICALS0.1%
93.7%
93AUPHAURINIA PHARMACEUTICALS0.1%
93.9%
94REPLREPLIMUNE GROUP0.1%
94.0%
95VERAVERA THERAPEUTICS CLASS A0.1%
94.1%
96MBXMBX BIOSCIENCES0.1%
94.2%
97VIRVIR BIOTECHNOLOGY0.1%
94.3%
98SRPTSAREPTA THERAPEUTICS0.1%
94.5%
99BCRXBIOCRYST PHARMACEUTICALS0.1%
94.6%
100NRIXNURIX THERAPEUTICS0.1%
94.7%

What are IBB's top holdings?

IBB's five largest holdings as of Nov 12, 2026 are GILD at 8.9%, AMGN at 8.3%, VRTX at 7.7%, REGN at 6.4% and MRNA at 6.2%.

How many holdings are in IBB?

IBB holds 243 positions as of Nov 12, 2026.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.